Check out our most popular compounded medications! Get Started
Clomiphene Citrate 50 mg Slow Release (MEM4) Oral Capsules are a specially formulated medication designed to treat certain disease states. These capsules are made with Methocel E4M, a controlled-release polymer that ensures the gradual release of the active ingredient, Clomiphene Citrate, over an extended period. This slow-release mechanism provides sustained therapeutic effects, reduces the need for frequent dosing, and enhances patient compliance.
Clomiphene Citrate is primarily used in the treatment of female infertility, particularly in cases related to problems with ovulation. It is also used in certain cases of male infertility, and unexplained infertility. The slow-release formulation of Clomiphene Citrate 50 mg ensures a steady and controlled release of the drug, providing a prolonged therapeutic effect and improved patient outcomes.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Clomiphene Citrate 50 mg Slow Release (MEM4) Oral Capsules are a specially formulated medication designed to provide a controlled and prolonged release of the active ingredient, Clomiphene Citrate. This formulation utilizes Methocel E4M, a type of controlled-release polymer, to encapsulate the medication. This innovative technology allows for the gradual release of the medication over an extended period of time, providing sustained therapeutic effects.
Clomiphene Citrate is a medication primarily used to treat infertility in women who do not ovulate, including those with polycystic ovary syndrome. It works by stimulating an increase in the amount of hormones that support the growth and release of a mature egg (ovulation). This slow-release formulation of Clomiphene Citrate is designed to maintain a steady level of the medication in the body, which can enhance its effectiveness and potentially improve treatment outcomes.
One of the key benefits of this slow-release formulation is the reduced dosing frequency. This can significantly improve patient compliance, as it is often easier for patients to adhere to a medication regimen that requires fewer daily doses. Furthermore, the sustained release of the medication can help to minimize potential side effects, as it avoids the peaks and troughs in blood concentration that can occur with immediate-release formulations.
Prescribers should note that while Clomiphene Citrate is a powerful medication for treating certain types of infertility, it is not suitable for all patients. It should not be used by women who are already pregnant, or those with liver disease, abnormal vaginal bleeding, an uncontrolled adrenal gland or thyroid disorder, or an ovarian cyst unrelated to polycystic ovary syndrome. As with all medications, it is important to discuss the potential risks and benefits with the patient before initiating treatment.
If you have any questions about this formulation, or would like further information, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is always here to help.
Clomiphene Citrate 50 mg Slow Release (MEM4) Oral Capsules are designed to gradually release the active ingredient, Clomiphene Citrate, over an extended period of time. This is achieved through the use of Methocel E4M, a type of controlled-release polymer. The polymer matrix of Methocel E4M swells when it comes into contact with gastric fluids, creating a gel-like barrier that controls the rate at which the drug is released into the body. This slow, steady release of medication ensures a sustained therapeutic effect, reducing the need for frequent dosing and improving patient compliance.
Clomiphene Citrate is a non-steroidal fertility medicine. It causes the pituitary gland to release hormones needed to stimulate ovulation (the release of an egg from the ovary). Clomiphene Citrate is used to cause ovulation in women with certain medical conditions (such as polycystic ovary syndrome) that prevent naturally occurring ovulation. By releasing the medication slowly, the Clomiphene Citrate 50 mg Slow Release (MEM4) Oral Capsules ensure a consistent level of these hormones in the body, promoting regular ovulation and increasing the chances of pregnancy.
It's important to note that while Clomiphene Citrate can help induce ovulation, it does not guarantee pregnancy. It simply increases the chances of ovulation, which is a necessary step in the process of conception. Furthermore, the use of Clomiphene Citrate should be under the supervision of a healthcare provider, as it can have side effects and may not be suitable for all patients. For example, it should not be used by women who have liver disease, abnormal vaginal bleeding, an uncontrolled adrenal gland or thyroid disorder, an ovarian cyst (unrelated to polycystic ovary syndrome), or if you are pregnant.
If you have any questions about Clomiphene Citrate 50 mg Slow Release (MEM4) Oral Capsules, or if you would like more information about how this medication works or its suitability for your specific circumstances, please don't hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is always here to help.
Clomiphene Citrate is primarily used as a treatment for certain types of infertility in women who are not going through menopause, particularly those who are unable to ovulate (ovulatory dysfunction). By stimulating the release of certain hormones necessary for ovulation, Clomiphene Citrate aids in successful conception. However, our formulation of Clomiphene Citrate 50 mg Slow Release (MEM4) Oral Capsules presents additional applications that extend beyond infertility treatment.
Studies have suggested that Clomiphene Citrate may be beneficial in increasing testosterone levels in men affected by hypogonadism or low testosterone levels, which can lead to symptoms such as reduced sex drive, low energy, and mood changes. Our slow-release formulation could provide a more stable and prolonged hormone yield, potentially improving symptom control and patient quality of life. This off-label application of Clomiphene Citrate should be considered and discussed with healthcare providers before initiating the treatment.
In addition, there is some evidence to suggest that Clomiphene Citrate could have potential uses in managing polycystic ovary syndrome (PCOS), a hormonal disorder common among women of reproductive age. PCOS can lead to prolonged or infrequent menstrual periods and excess androgen levels, and often results in extended periods without ovulation. In this regard, Clomiphene Citrate might aid in restoring regular ovulation in these patients.
It's important to note that every patient's medical condition is unique, and this medication should only be used as prescribed by a qualified healthcare provider. Please ensure that the potential benefits and risks are thoroughly discussed before deciding to use this medication for applications outside of its conventional use. Also, patients should inform their healthcare provider of all current and past health conditions, and should discuss possible interactions with other medications, food, or lifestyle factors. Moreover, patients should diligently observe any potential side effects or changes in symptoms, and communicate these to their healthcare provider promptly.
If you have any queries or need further clarification regarding these potential alternative uses of Clomiphene Citrate 50 mg Slow Release (MEM4) Oral Capsules, or about any other aspect related to this medication, please do not hesitate to contact us at Bayview Pharmacy.
Clomiphene Citrate 50 mg Slow Release (MEM4) Oral Capsules is a medication formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to gradually release the active medication over an extended period of time, offering sustained therapeutic effects and reducing the frequency of dosage.
The slow-release capsules are designed to offer sustained therapeutic effects over a longer period. This reduces dosing frequency and improves patient compliance, especially for those on multiple medications or those who may forget frequent doses. The prolonged-release profile allows the medication to have a lasting effect.
Methocel E4M is a type of controlled-release polymer used in the formulation of this medication. This component helps control the release of the active ingredient, ensuring a gradual and sustained release over an extended period.
Clomiphene Citrate 50 mg Slow Release (MEM4) Oral Capsules should only be used by patients prescribed this medication by their healthcare provider. As with all medications, it's important to follow the prescribed dosage and regimen.
It's best to store this medication as instructed by your pharmacist or healthcare provider. Typically, medications should be stored in a cool, dry place, away from direct sunlight and out of reach of children.
If you miss a dose, take it as soon as you remember. If it's close to your next dose, skip the missed dose and continue with your regular schedule. Never double up on doses to make up for a missed one. If you're unsure what to do, contact your healthcare provider.
No, the capsules should not be crushed or chewed. Doing so can interfere with the controlled-release mechanism and lead to the release of too much medication at once.
Before taking any other medications, it is important to discuss this with your healthcare provider as some medications may interact with the Clomiphene Citrate 50 mg Slow Release (MEM4) Oral Capsules.
All medications can cause side effects; however, the severity and types can vary among individuals. It's important to discuss potential side effects with your healthcare provider before starting any new medication, including the Clomiphene Citrate 50 mg Slow Release (MEM4) Oral Capsules.
In case of an overdose, contact your healthcare provider immediately or seek emergency medical attention. Symptoms of overdose may vary and can be serious. Therefore, it's crucial to only take the prescribed dose and to use the medication responsibly.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
